Enzo Biochem Inc. ($0.01 Par Value)

3.16-0.0900-2.77%Vol 471.11K1Y Perf 41.31%
Apr 20th, 2021 16:00 DELAYED
BID2.81 ASK3.77
Open3.17 Previous Close3.25
Pre-Market- After-Market3.16
 - -  - -%
Target Price
12.00 
Analyst Rating
— 0.00
Potential %
279.75 
Finscreener Ranking
★★★★★     59.93
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★+     54.32
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★     47.45
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap152.40M 
Earnings Rating
Buy
Price Range Ratio 52W %
44.59 
Earnings Date
15th Mar 2021

Today's Price Range

3.053.23

52W Range

1.804.85

5 Year PE Ratio Range

-100.90121.30

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
-5.95%
1 Month
-15.51%
3 Months
5.69%
6 Months
59.60%
1 Year
41.31%
3 Years
-48.62%
5 Years
-36.16%
10 Years
-16.62%

TickerPriceChg.Chg.%
ENZ3.16-0.0900-2.77
AAPL133.11-1.7300-1.28
GOOG2 293.63-8.7700-0.38
MSFT258.26-0.4800-0.19
XOM55.29-1.1900-2.11
WFC42.54-1.3400-3.05
JNJ166.483.79002.33
FB302.650.41000.14
GE13.06-0.4000-2.97
JPM149.27-3.3800-2.21
Financial StrengthValueIndustryS&P 500US Markets
1.90
2.30
0.25
0.50
-
Leverage Ratio 1.90
ProfitabilityValueIndustryS&P 500US Markets
41.40
-6.30
-3.50
-0.50
-10.21
RevenueValueIndustryS&P 500US Markets
96.55M
2.00
-7.22
-4.78
Earnings HistoryEstimateReportedSurprise %
Q01 2021-0.01-
Q04 2020--0.07-
Q03 2020--0.17-
Q02 2020--0.12-
Q01 2020--0.16-
Q04 2019--0.11-
Q03 2019--0.14-
Q02 2019--0.18-
Earnings Per EndEstimateRevision %Trend
1/2018 QR-0.010.00-
4/2018 QR0.00--
7/2018 FY-0.02--
7/2018 FY-0.030.00-
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume471.11K
Shares Outstanding48.23M
Trades Count2.55K
Dollar Volume822.77K
Avg. Volume1.13M
Avg. Weekly Volume319.56K
Avg. Monthly Volume347.57K
Avg. Quarterly Volume1.27M

Enzo Biochem Inc. ($0.01 Par Value) (NYSE: ENZ) stock closed at 3.16 per share at the end of the most recent trading day (a -2.77% change compared to the prior day closing price) with a volume of 471.11K shares and market capitalization of 152.40M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 448 people. Enzo Biochem Inc. ($0.01 Par Value) CEO is Elazar Rabbani.

The one-year performance of Enzo Biochem Inc. ($0.01 Par Value) stock is 41.31%, while year-to-date (YTD) performance is 25.4%. ENZ stock has a five-year performance of -36.16%. Its 52-week range is between 1.8 and 4.85, which gives ENZ stock a 52-week price range ratio of 44.59%

Enzo Biochem Inc. ($0.01 Par Value) currently has a PE ratio of -15.10, a price-to-book (PB) ratio of 2.60, a price-to-sale (PS) ratio of 1.62, a price to cashflow ratio of 10.70, a PEG ratio of 2.32, a ROA of -8.83%, a ROC of -11.07% and a ROE of -15.20%. The company’s profit margin is -10.21%, its EBITDA margin is -3.50%, and its revenue ttm is $96.55 Million , which makes it $2.00 revenue per share.

Of the last four earnings reports from Enzo Biochem Inc. ($0.01 Par Value), there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Enzo Biochem Inc. ($0.01 Par Value)’s next earnings report date is -.

The consensus rating of Wall Street analysts for Enzo Biochem Inc. ($0.01 Par Value) is (0), with a target price of $12, which is +279.75% compared to the current price. The earnings rating for Enzo Biochem Inc. ($0.01 Par Value) stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Enzo Biochem Inc. ($0.01 Par Value) has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Enzo Biochem Inc. ($0.01 Par Value) has a Neutral technical analysis rating based on Technical Indicators (ADX : 13.78, ATR14 : 0.19, CCI20 : -136.00, Chaikin Money Flow : -0.20, MACD : 0.07, Money Flow Index : 45.98, ROC : -5.52, RSI : 35.50, STOCH (14,3) : 10.42, STOCH RSI : 0.00, UO : 44.35, Williams %R : -89.58), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Enzo Biochem Inc. ($0.01 Par Value) in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Summary Rating--Strong Buy
1.00

Enzo Biochem Inc. ($0.01 Par Value)

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.

CEO: Elazar Rabbani

Telephone: +1 212 583-0100

Address: 527 Madison Avenue, New York 10022, NY, US

Number of employees: 448

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

48%52%

Bearish Bullish

62%38%

Bearish Bullish

56%44%

News

Stocktwits